Amyloidosis, Sarcoidosis, and Other ‘Rare but Not-to-Be-Missed’ Scalp Lesions Behind Hair Loss — Dr. Moriwaki at AVAN TOKYO Ginza on Reading Skin Signs of Systemic Disease2026.08.02

“Hair loss appears together with redness or firm nodules on the scalp” — when such symptoms are noticed, jumping straight to symptomatic hair-loss treatment based only on the assumption of AGA or female pattern hair loss carries a real risk of missing an underlying systemic disease. Sarcoidosis scalp lesions and skin lesions associated with amyloidosis are certainly not common, but they leave distinctive patterns of alopecia on the scalp and belong to a domain where ordinary hair regenerative medicine alone cannot cope. Dr. Moriwaki at AVAN TOKYO Ginza Hair Regenerative Medicine organizes the early signs of these diseases and where hair regenerative medicine using stem cell conditioned media should be positioned.

Key Points of This Article

・Sarcoidosis scalp lesions and cutaneous amyloidosis can present as alopecia accompanied by scalp induration, infiltrative erythema, and color change.

・These belong to the category of scarring alopecia; the same treatment design used for AGA yields poor results, and diagnosing the underlying disease takes top priority.

・History-taking for systemic symptoms (bilateral hilar lymphadenopathy, uveitis, cutaneous nodules, multi-organ involvement) and skin biopsy are used to reach a definitive diagnosis.

・Hair regenerative medicine with stem cell conditioned media is best positioned as a complementary means of “raising the baseline of the follicular environment” only after control of the underlying disease is established.

・Do not dismiss these as “too rare to consider”: when standard AGA treatment shows poor response or inflammatory signs accompany the hair loss, honest practice means coordinating with dermatology.

What Are Sarcoidosis Scalp Lesions?

Sarcoidosis is a multi-organ inflammatory disease of unknown cause, characterized by the formation of non-caseating epithelioid cell granulomas. Its incidence in Japan is only a few per 100,000, but lesions can involve the lungs, eyes, skin, heart, nervous system, and many other organs. Sarcoidosis scalp lesions on the head appear as one facet of cutaneous sarcoidosis.

Characteristic Findings on the Scalp

The representative appearance of sarcoidosis scalp lesions is alopecia patches accompanied by relatively well-demarcated infiltrative erythema and brownish or pinkish induration. Unlike ordinary alopecia areata — where “the skin looks healthy but only the hair is missing” — the clue here is that color change, firmness, and elevation are seen on the skin surface. In long-standing lesions, the follicles themselves are lost and the picture takes on the character of scarring alopecia; once destroyed, follicles will not regrow hair, leaving an irreversible change. Findings such as firmness that does not disappear when pressed, or an infiltrative feel that cannot be explained by mere itching or dandruff, are especially important.

Differentiation from Cutaneous Amyloidosis

Among other easily missed systemic diseases are scalp lesions associated with amyloidosis. In some systemic amyloidoses such as AL amyloidosis, purpura, papules, and alopecia patches on skin including the scalp have been reported. If a patient shows “purpura they don’t remember bumping into,” “an alopecic area that feels hard,” or “the same kind of purpura around the eyelids or eyes,” these are signs that should be suspected rather than dismissed as ordinary thinning. Localized macular cutaneous amyloidosis often appears on the trunk as a pigmentary type rather than the scalp, but the systemic types cannot be taken lightly because delayed diagnosis directly affects prognosis.

Why These Are Easily Mistaken for Ordinary Hair Loss

Several reasons underlie why these scalp lesions get filed away as “the usual thinning.” First, in their early phase the alopecia spreads diffusely and unevenly, making the appearance resemble female pattern hair loss (FAGA) or telogen effluvium. Second, they often lack strong pain or itching, so patients themselves tend to think “it will resolve on its own” and delay consultation. Third, color changes and firmness on the scalp are hard for a person to notice in a mirror, and it is common for these to be pointed out first by a hair stylist before medical consultation is finally sought.

On the clinical side, in an era where AGA-specialty clinics operate independently, medication or injection treatment may begin without passing through a dermatologist’s viewpoint, and the chance to recognize the underlying disease may be lost. Precisely for this reason, providers of hair regenerative medicine must also cultivate “an eye for excluding anything other than typical AGA.”

The Diagnostic Order When Suspecting Sarcoidosis Scalp Lesions

Systemic Symptoms to Elicit on History

Because sarcoidosis is a systemic disease, it is important to pick up not only scalp symptoms but also the following on history: a dry cough or exertional dyspnea lasting for months (pulmonary lesions); decreased vision, blurred vision, or redness (uveitis); erythema or nodules on the limbs (erythema nodosum or cutaneous sarcoid); bilateral lower-leg edema; unexplained low-grade fever or joint pain; palpitations or arrhythmia (cardiac sarcoidosis). When multiple items apply, referral to dermatology or respiratory internal medicine takes priority.

Skin Biopsy and Imaging Assessment

For definitive diagnosis of a scalp lesion, skin biopsy is needed. Demonstration of non-caseating epithelioid cell granuloma is the typical finding, and differential diagnoses such as mycobacterial infection and mycosis are pursued in parallel. Chest X-ray and chest CT are used to evaluate the presence of bilateral hilar lymphadenopathy (BHL). If amyloidosis is suspected, the amyloid type is identified by Congo red staining and immunostaining, and systemic evaluation is done with echocardiography, renal function tests, and serum free light chains.

How to Position Hair Regenerative Medicine with Stem Cell Conditioned Media

When there is “inflammatory and scarring hair loss caused by an underlying disease,” such as with sarcoidosis scalp lesions, pushing hair regenerative medicine with stem cell conditioned media as a stand-alone strategy tends not to yield the response one hopes for. Growth factors such as IGF-1, HGF, and VEGF contained in the conditioned media are thought to act on follicular stem cells and their niche environment, but in areas where the follicles themselves have been destroyed by chronic granulomatous inflammation, lost follicles cannot fundamentally be built anew.

A realistic order is therefore two-stage: (1) coordinate with dermatology and internal medicine to control the underlying disease, and (2) once active inflammation has subsided, aim to raise the baseline of the follicular environment with stem cell conditioned media in areas of residual, non-scarred follicles. Understanding that “treatment aimed at curing the underlying disease” and “treatment aimed at supporting the follicles” have different purposes, and assembling them in a time-ordered plan for each patient, is what honest practice looks like. For general guidelines on AGA and alopecia, please also consult the Japanese Dermatological Association.

Other topics on hair regeneration at AVAN TOKYO Ginza are collected on our hair regenerative medicine column index. Individual differences and limits are inherent to this field, but keeping the order of “assess inflammation and scarring first, then work on the follicular environment” reduces the risk of missing rare systemic disease and allows hair regenerative medicine to be delivered to those who truly need it.

Frequently Asked Questions

Q. I have an alopecic patch with a firm nodule on my scalp. Can this be handled with AGA treatment?

Hair loss accompanied by induration or infiltrative erythema does not match the picture of typical AGA (androgenetic alopecia). Underlying causes of scarring alopecia — such as sarcoidosis scalp lesions, cutaneous amyloidosis, or discoid lupus — should be suspected, and the priority is to establish a diagnosis at a dermatology clinic first. A safer order is to consider how to combine hair regenerative medicine only after a diagnosis has been made.

Q. If I am diagnosed with sarcoidosis, does that mean I cannot receive stem cell conditioned media treatment at all?

It is not uniformly contraindicated, but while there is active systemic inflammation, or during treatment with immunosuppressants or biologic agents, infection risk and interpretation of treatment response become difficult. As a rule, we consider it only once control of the underlying disease is stable. Coordinating with the primary physicians (dermatology, respiratory medicine) allows individual judgment of the timing, site, and intensity of the procedure.

Q. Besides the scalp, what else should I have checked for amyloidosis?

Systemic amyloidosis can deposit in many organs — heart, kidneys, nerves, gastrointestinal tract — and left alone it affects life prognosis. Systemic assessment including echocardiography, urinary protein and renal function tests, peripheral nerve testing, and serum free light chains, in coordination with hematology, cardiology, and dermatology, is indispensable. Scalp symptoms are only “the tip of the iceberg”; diagnosis takes priority over hair treatment.

Q. Do I really need to check for a “rare disease”?

The incidence is certainly not high, but if response to ongoing AGA treatment is poor, if the pattern of hair loss is atypical, or if there are color changes and firmness on the skin, it is well worth the suspicion. Rather than continuing an incorrect treatment plan, undergoing exclusion diagnosis at a dermatology clinic once ends up saving both time and money.

Q. Will the hair regenerative medicine clinic pick up on these signs?

Even with a physician who specializes in the hair field, it is important to choose a clinic that takes dermatological differential diagnosis seriously. Whether the clinic asks about scalp color, firmness, and systemic symptoms during consultation, and whether it will readily refer to dermatology when suspicion arises, are good markers of trustworthy hair regenerative medicine.

──────────────

Supervising Physician: Dr. Shin Moriwaki

Member of the Japan Society of Aesthetic Surgery (JSAS)

Member of the American Academy of Aesthetic Medicine

ECFMG Certificate

──────────────

📍AVAN TOKYO Ginza Hair Regenerative Medicine

English / 中文 / Tiếng Việt supported

Inquiries via DM / LINE / Website / Phone are welcome.